Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
In the study, the 5-year overall survival rate after a diagnosis of breast cancer was 77.6% for men, compared with 86.4% for women.
FDA says studies of new breast cancer treatments should allow enrollment of men as well as women.
Study finds the risk of breast cancer rises in transgender women taking hormone therapy but falls in trans men.
Male breast cancer warrior Wayne Dornan shares his experiences and his mission.
ABSOT sits down with Susan Brown of Susan G. Komen to learn about male breast cancer.
Ibrance appears safe and effective for men in real-world use.
Fast facts, common myths and misconceptions
Hormone therapy is safe in men with breast cancer, but side effects remain a challenge.
John Falk shares his experience and mission as a two-time male breast cancer survivor.
About 480 men are expected to die from breast cancer this year.
Men should be included in breast cancer clinical trials, experts say.
Direct action and legislative advocacy groups demand more awareness and research on metastatic breast cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.